Clinical Trial

Abbreviated Antithrombotic Therapy After PCI in Patients With AF and AMI

Study acronym: HERO-AF-AMI
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The aim of the study is to compare clinical outcomes between direct oral anticoagulant (DOAC) monotherapy versus dual antithrombotic therapy (DOAC plus clopidogrel) in patients with atrial fibrillation and acute myocardial infarction after percutaneous coronary intervention (PCI).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-05-07.
Trial Details
NCT Number NCT07583784
Lead Sponsor Chonnam National University Hospital
Conditions Myocardial Infarction (MI), ST-Segment Elevation Myocardial Infarction(STEMI), NSTEMI - Non-ST-Segment Elevation Myocardial Infarction, AF - Atrial Fibrillation
Enrollment 860 participants
Start Date 2026-07-01
Primary Completion 2031-12-31 (estimated)
Study Completion 2032-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-17